The Breast Cancer Liquid Biopsy Market represents one of the most trans-formative segments within molecular diagnostics. Liquid biopsy is a non-invasive blood test used to detect biological markers such as circulating tumor cells (CT-Cs), circulating tumor DNA (ct-DNA), and lysosomes shed by breast cancer tumors. https://www.databridgemarketresearch.com/